Desk

Trials & R&D

Clinical trial readouts, pipelines and the science behind new medicines.

Trials & R&D · 4h ago

UChicago Medicine finaliza la fase de construcción del Pabellón Oncológico de la Fundación AbbVie, acercando a la realidad una nueva era en la atención del cáncer

1 outlet AbbVie

Trials & R&D · 8h ago

Global Autoimmune Treatment Market to Reach USD 321.95 Billion by 2034, Driven by Rising Prevalence of Autoimmune Diseases, Growing Adoption of Biologics, and Advances in Precision Medicine Says Maximize Market Research

1 outlet

Trials & R&D · 9h ago

Muscle Cell Calcium Channel Structure, Synchronicity Could Advance Muscle Disease Therapeutics

1 outlet

Trials & R&D · 10h ago

Renibus Therapeutics Announces Participation at the Oppenheimer Private Life Sciences Company Showcase

1 outlet

Trials & R&D · 10h ago

JNC Targets Bigger Molecules with Cellufine

1 outlet Vaccines & mRNA

Trials & R&D · 10h ago

Pfizer: Poised For Gains With A New Drug Pipeline And Cost-Cutting Plans

1 outlet Pfizer

Trials & R&D · 11h ago

AC Immune: Buy Continued ACI-7104 Progress, PD, And Pipeline Expansions

1 outlet

Trials & R&D · 11h ago

Why we like Starbucks’ latest turnaround move — plus, two more wins for Eli Lilly

1 outlet Eli Lilly

Trials & R&D · 11h ago

Crispr Therapeutics: Why AI Giant Anthropic's Discovery Has Rocked Gene Editing

1 outlet Gene therapy & editing

Trials & R&D · 11h ago

Possible Drug-Drug Interactions Flagged for Older Americans

1 outlet

Trials & R&D · 12h ago

Riaan’s Therapeutic Odyssey – Chapter 4: The Drug Developers

1 outlet

Trials & R&D · 15h ago

J&J says analysis demonstrates potential of Tecvayli-Darzalex combo for multiple myeloma

2 outlets Johnson & Johnson

Trials & R&D · 15h ago

Acadia falls after mid-stage trial setback for Alzheimer’s psychosis therapy

2 outlets Alzheimer's drugs

Trials & R&D · 13h ago

Experimental Drug Could Reverse Multiple Sclerosis Damage

1 outlet

Trials & R&D · 13h ago

Cullinan drops after delaying early-stage trial data for arthritis therapy

1 outlet

Trials & R&D · 14h ago

The 30-Minute Medicine Problem

1 outlet

Trials & R&D · 14h ago

N-of-1 therapies to address rare diseases with no commercial interest

1 outlet

Trials & R&D · 14h ago

DME red flag in Merck Brunello phase III? Surrozen finishes rich

1 outlet Merck & Co. (MSD)

Trials & R&D · 14h ago

Acadia Pharmaceuticals: Remlifanserin Is In Trouble

1 outlet

Trials & R&D · 14h ago

Video on function-focused antibody discovery workflows with Envisia

1 outlet

Trials & R&D · 14h ago

MSD’s DME drug could challenge anti-VEGF reign, late-stage study suggests

1 outlet Merck & Co. (MSD)

Trials & R&D · 14h ago

Roche secures separate discovery deals with Atavistik, Earendil

1 outlet Roche

Trials & R&D · 14h ago

10-Year Data Back Early Start to Biologics in Arthritic Diseases

1 outlet

Trials & R&D · 15h ago

Sarepta to pay Regenxbio $39M to settle gene therapy claims; Vida eyes fourth fund

1 outlet Gene therapy & editing

Trials & R&D · 15h ago

Johnson County ClinTrials (JCCT) Rebrands as Sequoia Clinical Research

1 outlet Vaccines & mRNA

Trials & R&D · 15h ago

Six reasons to register for Drug Discovery Innovators & Investors UK Conference

1 outlet

Trials & R&D · 15h ago

Chronic Kidney Disease Market: 5 Emerging Therapies to Watch as the Treatment Landscape Expected to Evolve by 2036 | DelveInsight

1 outlet CAR-T & cell therapy

Trials & R&D · 16h ago

Acadia slides on Phase 2 miss in Alzheimer’s psychosis but keeps moving asset forward

1 outlet Alzheimer's drugs

Trials & R&D · 16h ago

ELEPHAS BIOSCIENCES AND TES PHARMA COLLABORATE TO ADVANCE TRANSLATIONAL RESEARCH FOR LUNG CANCER THERAPY

1 outlet

Trials & R&D · 16h ago

Novo Nordisk: Capital Markets Day Reveals Its Next Growth Engine

1 outlet Novo Nordisk

Trials & R&D · 16h ago

United Therapeutics, Sagimet drop after Goldman Sachs Sell ratings

1 outlet

Trials & R&D · 16h ago

Roche, Atavistik Bio partner on allosteric drug discovery

1 outlet Roche

Trials & R&D · 17h ago

CancerIQ Deepens EHR Integrations to Identify and Guide More Patients Through Cancer Screening, Testing and Surveillance

1 outlet

Trials & R&D · 17h ago

Australia, CAR-T therapy, and solid tumours

1 outlet CAR-T & cell therapy

Trials & R&D · 20h ago

Genialis and Inventia to enhance pancreatic cancer treatment testing

2 outlets

Trials & R&D · 18h ago

Merck’s return to ophthalmology snags first success

1 outlet Merck & Co. (MSD)

Trials & R&D · 18h ago

Lilly sets aside up to $3.25B to tackle critical unmet need targets with InnoCare

1 outlet Eli Lilly

Trials & R&D · 18h ago

Precision Radiation Therapy Alone Doubles Historical Survival Rates for Inoperable Lung Cancer, Landmark Lancet Trial Finds

1 outlet

Trials & R&D · 18h ago

Kyverna builds case for CAR-T in stiff person syndrome

1 outlet CAR-T & cell therapy

Trials & R&D · 18h ago

Merck’s diabetic macular edema therapy succeeds in Phase 2b/3 trial

1 outlet Merck & Co. (MSD)

Trials & R&D · 18h ago

GSK slammed for ‘grossly misleading’ and ‘totally unacceptable’ behavior

1 outlet GSK

Trials & R&D · 19h ago

Lilly forges $3.35bn alliance with China's InnoCare

1 outlet Eli Lilly

Trials & R&D · 19h ago

HLL Lifecare to expand pharmacy network to 600 outlets, add 4,500 jobs

1 outlet

Trials & R&D · 19h ago

STAT+: Why Gilead can’t stop talking about its ambitions in immunology

1 outlet Gilead Sciences

Trials & R&D · 20h ago

From activity to accountability: the omnichannel metrics that pharma leadership actually acts on

1 outlet

Trials & R&D · 20h ago

Enveda nabs $311m to progress nature-derived drug pipeline

1 outlet

Trials & R&D · 20h ago

Acadia misses mark in Alzheimer’s but concludes phase 3 ‘absolutely worth’ pursuing

1 outlet Alzheimer's drugs

Trials & R&D · 20h ago

Quotient Sciences proprietary AI-enhanced solution optimises formulation in clinical study

1 outlet

Trials & R&D · 21h ago

Roivant reports top-line data from IMVT-1402 CLE trial

1 outlet

Trials & R&D · 21h ago

STAT+: In radiology, AI is blurring the line between technology development and clinical practice

1 outlet

Trials & R&D · 21h ago

Opinion: STAT+: A moment of reckoning for preventive cardiology and the precision medicine revolution

1 outlet

Trials & R&D · 22h ago

Merck sees pivotal victory for $3B eye disease prospect

1 outlet Merck & Co. (MSD)

Trials & R&D · 23h ago

AI-enabled pharmacovigilance, with Updesh Dosanjh

1 outlet

Trials & R&D · 23h ago

Biology + chemistry: changing the way drug developers think about innovation and therapeutic design (part I)

1 outlet

Trials & R&D · yesterday

Biogen springs social media kidney health campaign with Olympic gymnast Suni Lee

1 outlet Biogen

Trials & R&D · yesterday

Generic Remedy crosses 700+ franchise outlets across 9 States

1 outlet

Trials & R&D · yesterday

From endoscopic brow lifts to arm lifts, how patients are changing their faces and bodies without going fully under.

1 outlet

Trials & R&D · yesterday

Menopausal Hormone Therapy Thrombotic Risk Varies by Dose, Route of Administration

1 outlet

Trials & R&D · yesterday

Phase 3 Data Could Make Roche Drug a Contender to Treat Rare Kidney Disease`

1 outlet Roche

Trials & R&D · yesterday

Arcturus sees positive results from mid-stage trial of RCT-810 in OTC deficiency

1 outlet